Wire · regulatory
HHS plans two new FDA deputy commissioner roles, including AI
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 25 August 2026 · Fusion42 review
The US Department of Health and Human Services plans to create two new FDA deputy commissioner roles, one focusing on technology and artificial intelligence and the other on drugs, aiming to strengthen agency influence and oversight of AI in medical product regulation.
This Wire brief sits within Fusion42's coverage of Healthtech Infrastructure, and 4 sources have reported it between 25 Aug 2026 and 26 Aug 2026.
◆ ◆ The Wire takeaway
You must prepare for tighter AI oversight at the FDA as a new deputy commissioner will focus exclusively on AI and technology. This creates opportunities to engage early with regulatory processes for AI-enabled health products.
◆ Coverage
4 sources · first reported 25 Aug 2026 · latest 26 Aug 2026
◆ Related on Wire
◆ Topics